Recipients of Grants

The Wyck Foundation (Wyck) began grantmaking activities in 2015. Wyck has formed an alliance with the Myotonic Dystrophy Foundation (MDF) to support selected basic and translational research projects, as a component of its efforts to accelerate therapy development. Information on the Myotonic Dystrophy Foundation is available here

Wyck Foundation grant recipients include:

Research Grant Awards

Active

Research Grant Awards

  • The University of Utah, Primary Investigator Nicholas Johnson, M.D.: Population Based Prevalence Study in Myotonic Dystrophy Type-1 and Type-2
  • The Jackson Laboratory, Primary Investigator Cathleen Lutz, Ph.D.: Building a Better Mouse
  • Massachusetts General Hospital, Primary Investigator Thurman Wheeler, M.D.: Extracellular RNA as Biomarkers of Myotonic Dystrophy
  • RUCDR Infinite Biologics, Rutgers University, Primary Investigator Michael Sheldon, Ph.D.: DM Cell Line Library
  • University of Florida, Primary Investigator Donovan Lott, D.PT.: Development of Magnetic Resonance Imaging as an Endpoint in Myotonic Dystrophy Type 1
  • Newcastle University, Primary Investigator Hanns Lochmuller, Ph.D.., PHENO-DM1 - DM1 Deep Phenotyping to Improve Delivery of Personalized Medicine and Assist in the Planning, Design and Recruitment of Clinical Trials
  • University of Florida - Icagen, Inc. Collaboration, Primary Investigators Andrew Berglund, Ph.D., University of Florida and Paul R. August, Ph.D., Vice President, Department Head -Discovery Biology, Icagen, Inc.: Inhibiting Transcription of CUG/CCUG Expanded Repeats with Small Molecules
  • Myotonic Dystrophy Foundation: Support for research capacity development and advocacy support 2015-2017

Fellowship Awards

  • Anwesha Banerjee, Ph.D., Emory University: Mechanism of CNS-associated behavioral dysfunction in novel mouse model of Myotonic Dystrophy Type 1
  • Kaalak Reddy, Ph.D., The University of Florida: Pre-clinical investigations of small molecule-mediated targeting of toxic RNA production in DM2
  • Ian DeVolder, Ph.D., University of Iowa, U.S.: Structural and Functional Connectivity in the Brains of Patients with Adult and Late Onset Myotonic Dystrophy Type 1 (DM1) - A Potential Biomarker for Disease Progression
  • Melissa M. Dixon, Ph.D., University of Utah, U.S.: Evaluation of Functional Connectivity as a Brain Biomarker in Congenital Myotonic Dystrophy
  • Benjamin Gallais, Ph.D., Universite de Sherbrooke, Canada: A 14-Year Longitudinal Study of Cognition and Central Nervous System Involvement in Adult and Late-Onset Phenotypes of Myotonic Dystrophy Type 1
  • Ginny R. Morriss, Ph.D., Baylor University, U.S.: Mechanisms of Skeletal Muscle Wasting Caused by Expanded CUG Repeat RNA
  • Laura Valentina Renna, Ph.D.,  IRCCS-Policlinico San Donato, Italy: A New Approach of Pathomolecular Mechanisms in Myotonic Dystrophy Insulin Resistance by Nutrigenomics
  • Lukasz Sznajder, Ph.D., University of Florida, U.S.: Myotonic Dystrophy Type 2 - Mouse Models, Pathomechanism and Therapy
  • Ranjan Batra, Ph.D., University of California San Diego, U.S.: Studying Genome-Wide MBNL-RNA Structure Interactions in Neuronal Development and Myotonic Dystrophy
  • Melissa Hinman, Ph.D., University of Oregon, U.S.: An Investigation of the Cellular and Microbial Etiologies of Gastrointestinal Pathologies in Myotonic Dystrophy Using the Zebrafish

Previous

Research Grant Awards

  • Stanford University, Primary Investigator John Day, M.D., Ph.D.: Myotonic Dystrophy Clinical Research Network Multicenter Study of Natural History and Genetic Modifiers in Myotonic Dystrophy Type 1
  • University of Utah, Primary Investigator Nicholas Johnson, M.D.: Myotonic Dystrophy Clinical Research Network Multicenter Study of Natural History and Genetic Modifiers in Myotonic Dystrophy Type 1
  • Ohio State University, Primary Investigator John Kissel, M.D.: Myotonic Dystrophy Clinical Research Network Multicenter Study of Natural History and Genetic Modifiers in Myotonic Dystrophy Type 1
  • University of Kansas Medical Center, Primary Investigator Jeffrey Statland, M.D.: Myotonic Dystrophy Clinical Research Network Multicenter Study of Natural History and Genetic Modifiers in Myotonic Dystrophy Type 1
  • University of Florida, Primary Investigator S.H. Siubramony, M.D.: Myotonic Dystrophy Clinical Research Network Multicenter Study of Natural History and Genetic Modifiers in Myotonic Dystrophy Type 1
  • European Neuromuscular Centre, Primary Investigator Alexandra Breukel, Ph.D., Workshop Support - Myotonic Dystrophy - Developing a European Consortium for Care and Therapy
  • University of Utah, Primary Investigator Nicholas Johnson, M.D.: Phase I Development and Validation of Screening Technology for Myotonic Dystrophy Population-Based Prevalence Study

Fellowship Awards

  • Viachaslau Bernat, Ph.D., The Scripps Research Institute - Florida, US: Precise Lead Therapeutics for Myotonic Dystrophy via in cellulo Synthesis

Additional award information will be posted to this page as it becomes available. For questions please contact: info@wyckfoundation.org

Improving the quality of life of people living with myotonic dystrophy through funding for basic and translational research efforts and patient advocacy.